Soleus Capital Management, L.P.
Annual return '25
+33.7%
SPY '25
+17.7%
Alpha
+16.0ptsvs SPY
Invested
$2.5B
Holdings
94
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 95%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$KRYS
KRYSTAL BIOTECH INC
Held since at least Q1 2024
12.1%
02
$CELC
CELCUITY INC
Held since at least Q1 2024
5.9%
03
$TGTX
TG THERAPEUTICS INC
Held since at least Q1 2024
5.4%
04
$PODD
INSULET CORP
Held since at least Q1 2024
4.8%
05
$NVCR
NOVOCURE LTD
Held since at least Q1 2024
4.6%
06
$UTHR
UNITED THERAPEUTICS CORP DEL
Held since at least Q1 2024
4.5%
07
$PRAX
PRAXIS PRECISION MEDICINES I
Held since at least Q1 2024
4.3%
08
$VCEL
VERICEL CORP
Held since at least Q1 2024
3.3%
09
$ALKS
ALKERMES PLC
Held since at least Q1 2024
2.8%
10
$ANIP
ANI PHARMACEUTICALS INC
Held since at least Q1 2024
2.6%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 06:52 UTC.